Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Cash: 2021-2025

Historic Change in Cash for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$3.8 million.

  • Biofrontera's Change in Cash fell 153.78% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $544,000, marking a year-over-year increase of 199.09%. This contributed to the annual value of $4.6 million for FY2024, which is 128.76% up from last year.
  • Biofrontera's Change in Cash amounted to -$3.8 million in Q3 2025, which was down 170.08% from $5.5 million recorded in Q2 2025.
  • Biofrontera's Change in Cash's 5-year high stood at $22.8 million during Q4 2021, with a 5-year trough of -$10.4 million in Q4 2022.
  • Moreover, its 3-year median value for Change in Cash was -$1.5 million (2024), whereas its average is -$1.3 million.
  • Examining YoY changes over the last 5 years, Biofrontera's Change in Cash showed a top increase of 870.46% in 2025 and a maximum decrease of 266.53% in 2025.
  • Over the past 5 years, Biofrontera's Change in Cash (Quarterly) stood at $22.8 million in 2021, then slumped by 145.37% to -$10.4 million in 2022, then skyrocketed by 79.93% to -$2.1 million in 2023, then spiked by 245.84% to $3.0 million in 2024, then plummeted by 153.78% to -$3.8 million in 2025.
  • Its last three reported values are -$3.8 million in Q3 2025, $5.5 million for Q2 2025, and -$4.1 million during Q1 2025.